TRU-PE: A Universal, Trackable Prime Editor Toolkit for Robust Single- and Multi-Locus Genome Engineering

The authors present TRU-PE, a versatile toolkit utilizing a split-vector architecture and fluorescence-guided enrichment to overcome delivery and efficiency barriers in prime editing, thereby enabling robust single- and multi-locus genome engineering that accelerates functional genomics and therapeutic development.

The Gist

Imagine you are trying to fix a typo in a very long, complex instruction manual (your DNA) inside a tiny, fragile factory cell. For years, scientists have had a tool called Prime Editing that can do this perfectly without breaking the manual. But there's a catch: the tool is so big and heavy that it's hard to get it inside the factory, and once inside, it's hard to know if the workers actually have the tool or if they just pretended to have it.

This paper introduces TRU-PE, a new "toolkit" that solves these problems. Here is how it works, explained with everyday analogies:

1. The Problem: The "Oversized Moving Truck"

Think of the Prime Editor as a massive moving truck carrying all the tools needed to fix the DNA.

• The Issue: This truck is so huge (over 12,000 letters long) that it can't fit through the narrow gates of many important cell types (like stem cells or immune cells).
• The Old Way to Check: Previously, scientists used a "bribe" (antibiotics) to see if the truck got in. They would poison the factory unless the workers had the truck. But this is messy: it kills the good workers, takes a long time, and some workers cheat by pretending to have the truck just to survive the poison.

2. The Solution: The "Split Delivery & Glow-in-the-Dark" System

The TRU-PE team realized they didn't need one giant truck. Instead, they broke the tools into three smaller, manageable delivery vans.

• The Split: They split the massive editor into three parts:
  1. Van A carries the "Scissors" (nCas9).
  2. Van B carries the "Glue/Writer" (Reverse Transcriptase).
  3. Van C carries the "Map" (the guide RNA).
• The Glow: Each van is painted a different bright color (Blue, Green, or Red).
• The Magic: Instead of using poison to check who got the tools, the scientists use a special machine (FACS) to look for cells that are glowing all three colors at once.
  • If a cell is only glowing blue, it's missing tools.
  • If it's glowing blue, green, and red, it has the perfect amount of everything.
  • This ensures that only the cells with the complete, working toolkit are kept, making the editing much more efficient and less toxic.

3. The Superpower: Editing 10 Things at Once

Usually, trying to fix multiple typos in a manual at the same time is a nightmare; the tools get confused or run out of energy.

• The Analogy: Imagine trying to fix 10 different sentences in a book simultaneously. Most systems can only handle 3.
• TRU-PE's Trick: Because they split the tools into three vans and used the "glow" system to ensure every cell has a surplus of tools, they can now fix up to 10 different locations in the DNA at the exact same time. It's like having a team of 10 expert editors working in perfect sync because everyone has exactly the right amount of supplies.

4. The Real-World Test: Building a "Disease Simulator"

To prove this works, the scientists used TRU-PE to build a model for a complex blood disease called GATA2 deficiency.

• The Challenge: This disease isn't caused by just one mistake; it's a combination of a genetic flaw you are born with, plus two other mistakes that happen later in life.
• The Old Way: To study this, scientists had to fix one mistake, wait months for the cells to grow, then fix the second, then the third. It took forever and the cells often got sick from the stress.
• The TRU-PE Way: They dropped all three "mistakes" into the cells at once. In a single round of editing, they created a library of cells with every possible combination of these errors.
• The Result: They grew these cells into blood cells and watched what happened. They discovered that one specific combination of errors caused a severe blockage in blood production, a detail they could only see because they could build the complex model so quickly and accurately.

Why This Matters

TRU-PE is like upgrading from a clunky, heavy-duty drill to a sleek, modular power tool set that fits in your pocket.

• It's Universal: It works on stubborn cells that previously refused to be edited.
• It's Precise: It avoids the "collateral damage" of old methods.
• It's Fast: It turns months of work into weeks.

This toolkit doesn't just make editing easier; it opens the door to fixing complex diseases that involve multiple genetic errors, bringing us closer to cures for conditions like leukemia, heart disease, and neurodegenerative disorders.

Technical Summary

1. Problem Statement

Prime Editing (PE) is a transformative genome engineering technology capable of precise nucleotide substitutions, insertions, and deletions without double-strand breaks. However, its widespread adoption is hindered by three critical bottlenecks:

• Payload Size and Delivery: Standard PE vectors exceed 12 kb, making them difficult to deliver into recalcitrant cell types (e.g., human induced pluripotent stem cells [hiPSCs], primary T cells) via plasmid transfection or viral packaging.
• Inefficient Selection: Conventional selection relies on antibiotic resistance (e.g., puromycin), which is time-consuming, toxic to sensitive cells, and fails to enrich for cells with optimal editor stoichiometry, often resulting in high background "escapees."
• Limited Multiplexing: Existing multi-locus PE approaches are inefficient, typically limited to modifying three or fewer loci simultaneously due to compounding biological and technical inefficiencies. This restricts the modeling of complex polygenic diseases driven by epistatic interactions.

2. Methodology

The authors developed TRU-PE (Trackable, Robust, and Universal Prime Editor), a toolkit designed to overcome these barriers through a split-vector architecture and fluorescence-guided enrichment.

• Tripartite Split-Architecture: The PE machinery (nCas9, Reverse Transcriptase-MLH1dn, and the pegRNA/nickingRNA array) is decoupled into three size-balanced plasmids (each <9 kb). This reduces the payload size per vector, significantly improving transfection efficiency in difficult cell lines.
• Fluorescence-Guided Enrichment (FACS): Each of the three plasmids is coupled with a distinct fluorescent reporter (BFP, GFP, and RFP). This allows for the isolation of cells that have successfully taken up and expressed all three components via Fluorescence-Activated Cell Sorting (FACS), ensuring optimal stoichiometry without the toxicity of antibiotics.
• Polycistronic RNA Array (TRU-MPE): To enable multiplexing, the RNA vector utilizes a human cysteine tRNA (hCtRNA) promoter to drive a polycistronic array of sgRNAs/pegRNAs. This allows for the simultaneous expression of multiple guide RNAs from a single vector.
• Stoichiometric Tuning: The system allows researchers to independently modulate the dosage of each vector component to optimize editing purity and minimize unintended edits (e.g., bystander mutations).
• Reporter Systems: The authors engineered split-GFP reporters to monitor editor assembly and frameshift RFP reporters to link fluorescence directly to successful editing events.

3. Key Contributions

• Universal Delivery Platform: TRU-PE provides a user-friendly, plasmid-based workflow compatible with standard laboratory settings, democratizing access to high-efficiency PE.
• Scalable Multiplexing: The derivative TRU-MPE system enables the simultaneous editing of up to ten genomic loci in a single round, a significant leap from the previous limit of ~3 loci.
• Compatibility with Evolved Editors: The architecture serves as a universal "operating system" that can integrate and enhance the performance of state-of-the-art PE variants (e.g., PE6e, PE7, and P3/P4 dimerization domains).
• Isogenic Disease Modeling: The platform successfully generated a comprehensive library of isogenic hiPSC clones with combinatorial mutations in a single editing step, bypassing the months-long iterative editing processes previously required.

4. Key Results

• Enhanced Editing Efficiency:
  • Recalcitrant Cells: TRU-PE achieved 16-fold higher efficiency in HeLa cells and 15.7-fold in MCF7 cells compared to puromycin-selected controls.
  • hiPSCs: In human iPSCs, editing efficiency increased by up to 21-fold.
  • Lentiviral Delivery: In suspension cells (Jurkat T cells) and HEK293T cells, lentiviral TRU-MPE showed 9- to 71-fold increases in efficiency compared to lentiviral MPE controls.
• Robust Multiplexing:
  • The system successfully edited 10 loci simultaneously. Single-cell NGS analysis revealed that ~6% of sorted cells contained edits at all 10 sites, with the majority having concurrent edits at 6–7 loci.
  • Editing was achieved without position-dependent biases or increased bystander mutation activity.
• Improved Purity via Stoichiometry: By reducing the input of nCas9 or pegRNA vectors while maintaining high RT levels, the authors significantly suppressed unintended edits (indels/mismatches), yielding a purer edited population.
• Disease Modeling (GATA2 Deficiency):
  • Using TRU-MPE, the team generated hiPSC lines with combinations of germline GATA2 mutations and somatic SETBP1 and ASXL1 mutations in a single round.
  • Differentiation assays revealed genotype-specific defects: ASXL1 single mutants exhibited severe myeloid differentiation blocks comparable to GATA2 loss, while SETBP1 mutants maintained robust hematopoietic potential. This clarified the epistatic interactions driving myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).

5. Significance

TRU-PE represents a paradigm shift in genome engineering by solving the "delivery paradox" of Prime Editing. By decoupling the editor components and utilizing fluorescence-based enrichment, it bypasses the limitations of payload size and antibiotic toxicity.

• For Basic Research: It enables the rapid construction of complex polygenic disease models and the dissection of epistatic networks that were previously inaccessible.
• For Therapeutics: It offers a streamlined path for engineering cell therapies (e.g., CAR-T cells) where multiple genomic edits (knockouts and insertions) are required simultaneously.
• For Synthetic Biology: The ability to edit up to 10 loci efficiently lays the groundwork for large-scale regulatory network engineering and synthetic genome debugging.

In conclusion, TRU-PE provides a scalable, robust, and universal framework that accelerates functional genomics and therapeutic development by making complex, multi-locus prime editing accessible and efficient across diverse cell types.